Bollinger Lisa sold APGE
September 3, 2026 · Form 4 insider transaction
Bollinger Lisa sold 8,112 shares of Apogee Therapeutics Inc, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,112
Price
N/A
Total value
N/A
InsiderBollinger Lisa
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateSeptember 3, 2026
Filing dateSeptember 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each reported option was disposed of, pursuant to the Agreement and Plan of Merger, dated as of June 18, 2026, among Andor LLC, Andor Merger Co., the Issuer and AbbVie Inc., in exchange for a cash payment equal to the excess of the merger consideration of $135.11 over the exercise price of such option.; The reported options were vested as of the date of the Merger or became fully vested in connection with the Merger.